Drug Interactions. Stephen Kravcik MD FRCPC Division of General Medicine University of Ottawa
|
|
- Kathlyn Doyle
- 6 years ago
- Views:
Transcription
1 Drug Interactions Stephen Kravcik MD FRCPC Division of General Medicine University of Ottawa
2 Conflicts of Interest None with pharmaceutical industry Consultant with PHAC CADTH CMPA WSIB
3 Clinical Burden of DDIs 3-5% of preventable in-hospital adverse drug reactions Majority are unanticipated and unrecognized until after the occurrence
4 P-glycoprotein Two big players
5 Cytochrome P450
6 Teaching about DDIs Interesting, if you re a nerd Pretty dry otherwise
7
8 DOACs Antibiotics HIV Meds Warfarin Miscellaneous Cool drug AEs
9 DOACS 100 A 57yo woman with severe COPD, on chronic azithromycin, develops A fib and requires OAC. With which DOAC are macrolides safely taken?
10 DOACS 100 None DOAC metabolism is, at least in part, controlled by P-glycoprotein All macrolides are strong PGP inhibitors Therefore, macrolide use will increase all DOAC activity, and may lead to an increase in bleeding Fralick M, Juurlink DN, Marras T. Bleeding associated with coadministration of rivaroxaban and clarithromycin. CMAJ Jun 14;188(9):669-72
11
12
13 DOACS 200 An HIV+ man on Genvoya, which has a strong CYP3A4 inhibitor, is found to have A fib. He has terrible veins and wishes to avoid warfarin use. Which DOAC is safest with a strong inhibitor of CYP450 3A4?
14 DOACS 200 Dabigatran Its is minimally metabolized by any of the cytochromes The other DOACS are significantly metabolized by CYP450, so inhibitors or inducers of these enzymes will have a significant effect on the effectiveness or safety of DOACs But dabigatran is still not terribly safe with HIV Pis as they inhibit Pgp So best change ARVs or use warfarin
15 DOACs 300 Which is least safe with a DOAC when treating a fib: a beta blocker, verapamil or digoxin?
16 DOACs 300 Verapamil is a strong inhibitor of PGP, and may lead to an increased risk of bleeding if on a DOAC.
17 DOACs 400 Which anticonvulsant is safest with a rivaroxaban or apixaban: phenytoin, carbamazepine or valproic acid?
18 DOACs 400 Valproic acid Phenytoin and carbamazepine are strong inducers of CYP450 3A4 and inducers of PGP, so may dramatically reduce DOAC effectiveness If these are required, use warfarin: affected by CYP450 but can follow the INR
19 DOACs 500 Is amiodarone safe with DOACS?
20 DOACs 500 Moderate CYP3A4 and mild-mod P- gp inhibitor Dabi levels increase 40% Use with caution with any DOAC
21 Antibiotics 100 Which antituberculous drug is the most potent known CYP450 inducer?
22 Antibiotics 100 Rifampin Potential substrates: All calcium channel blockers All benzos except for lorazepam, oxazepam and temazepam Statins (not much with pravastatin) Estrogens Apixaban, rivaroxaban, warfarin
23 Antibiotics 200 A 65 yo female with dyspepsia, who loves her TUMS, who has not seen a doctor in years, fails treatment of a sensitive gram- UTI with cipro. Why?
24 Antibiotics 200 Tums and any other di- or tri-valent cations may bind quinolones and reduce their absorption Tums et al should be given at least 2 hours before or 6 hours after a quinolone dose The same holds for iron, calcium supps and phosphate binders Do not take with dairy products Also happens with tetracyclines
25 Antibiotics 300 A depressed middle aged bodybuilder on citalopram receives linezolid for an MRSA cellulitis. He develops myoclonus and hyperreflexia. Why?
26 Antibiotics 300 Linezolid use may lead to serotonin syndrome if taken with drugs that increase serum serotonin levels: Antidepressants Analgesics SSRIs Paroxetine Sertraline Fluoxetine Fluvoxamine Citalopram Escitalopram SNRIs Venlafaxine Duloxetine Mirtazapine Tricyclic antidepressants Amitriptyline Clomipramine Desipramine Doxepin Imipramine Nortriptyline Protriptyline NRIs Trazodone Nefazodone MAOIs Tranylcypromine Phenelzine Selegiline Tramadol Meperidine Methadone Dextromethorphan Dextropropoxyphene Pentazocine Antituberculosis Isoniazid Anxiolytics Buspirone Hypnotics l-tryptophan Migraine Sumatriptan and other triptans Stimulants Amphetamine and derivatives Antineoplastic Procarbazine Dopamine agonists Bromocriptine Illicit psychotropics Cocaine Lysergic acid diethylamide Ecstasy Methylenedioxyamphetamine N-methyldiethanolamine Herbals 3,4-Methylenedioxymethamphetamine St. John's Wort (Hypericum perforatum) Ginseng (Panax ginseng)
27 Antibiotics 400 A 55 yo male with ALL, on methotrexate, becomes neutropenic when treated for a GAS pharyngitis. Why?
28 Antibiotics 400 Penicillins block the tubular secretion of methotrexate and can lead to a significant increase in plasma MTX levels, leading to greater hepatic, renal and bone marrow toxicity of MTX NSAIDs cause renal efferent arteriolar vasoconstriction and relative renal hypoperfusion. This can lead to MTX bio-accumulation and toxicity.
29 Antibiotics 500 What happens when you mix meropenem and valproic acid?
30 Antibiotics 500 Valproic acid levels plummet The nature of the interaction is uncertain Increasing valproic acid doses will frequently not overcome the reaction and puts the patient at risk of toxicity when the meropenem is stopped
31 HIV Meds 100 Which two HIV antiretroviral components are potent P4503A4 inhibitors?
32 HIV Meds 100 Ritonavir and cobicistat Ritonavir in Norvir, Kaletra Cobicistat in Stribild, Genvoya, Prezcobix
33 HIV Meds 100
34 HIV Meds 200 Which inhaled corticosteroid is safest for someone on ritonavir
35 HIV Meds 200 The safest ICS is Qvar (beclomethasone) Virtually all other inhaled (oral and nasal) CS are P450-metabolized Many case reports of hypercortisolism when taken with potent P450 inhibitors
36 HIV Meds 300 Which calcium channel blocker is safest in someone taking Genvoya?
37 None. HIV Meds 300. All CCBs are CYP450 3A4 metabolized, and their bioavailability dramatically increased when used with ritonavir (Norvir, Kaletra) or cobicistat (Prezcobix, Stribild, Genvoya)
38 HIV Meds 400 Which is the safest statin with ritonavir? Atorvastatin Simvastatin Lovastatin Pravastatin Rosuvastatin
39 HIV Meds 400 Which is the safest statin with ritonavir? Atorvastatin limit to 20 mg/day Simvastatin DO NOT USE Lovastatin DO NOT USE Pravastatin no concerns Rosuvastatin - limit to 10 mg/day
40 HIV Meds 500 Which of these significantly interacts with ritonavir/cobicistat? Diazepam Sildenafil Ergotamine Ticagrelor
41 HIV Meds 500 All do Diazepam (only safe BDZs are lorazepam, temazepam and oxazepam) Sildenafil (AUC increases 4x; same with other PDE 5 inhibitors) Ergotamine (absolute CI) Ticagrelor (AUC increase 7x)
42 Warfarin 100 Is warfarin pharmacology straightforward?
43 . Warfarin 100 Not a chance Warfarin is a racemic mixture of its R-isomer (less potent) and S-isomer (more potent). S-warfarin is metabolized primarily by the CYP 2C9 isoenzyme whereas R-warfarin is metabolized by CYP 1A2 and 3A4. Depending on the dominant isoenzyme inhibited by the interacting drug, the effect on warfarin may or may not be clinically significant. Consequently, drugs that impact CYP 2C9 metabolism can be expected to have a disproportionate effect on the INR There are numerous agents, such as metronidazole, trimethoprim/sulfamethoxazole (TMP/SMX), and amiodarone, that are commonly prescribed to older individuals that inhibit the CYP 2C9 pathway These medications, when used in conjunction with warfarin have significant effects on the INR and bleeding risk. In addition, while warfarin clearance is not affected by renal dysfunction, serum levels of interacting drugs (such as ciprofloxacin or TMP/SMX) may increase with renal dysfunction, enhancing the interaction. Absorption is affected by gut flora, whih is affected by antoibiotics
44 Warfarin 200 Is there an oral antibiotic that is free of the potential to alter warfarin absorption or metabolism?
45 Warfarin 200 No Almost all antibiotics can potentiate the effects of warfarin by: Alteration of intestinal flora that produce vitamin K Inhibition or induction of cytochrome P450 Unless the INR can be monitored every other day, ciprofloxacin, macrolides, metronidazole and TMP-SMX generally should not be prescribed to patients who are taking warfarin
46 Warfarin 300 Is acetaminophem safe with warfarin?
47 Warfarin 300 No As few as seven 325-mg tablets of acetaminophen can lead to increased warfarn effect. The proposed mechanism is the inhibition of CYP450 by acetaminophen resulting in decreased metabolism of warfarin.
48 Warfarin 400 Do statins affect warfarin-related anticoagulation?
49 Warfarin 400 Yes. Statins may inhibit CYP450 metabolism of warfarin displace warfarin from its binding site on albumin. Unanticipated elevated INR with warfarin has been reported with concomitant use of fluvastatin, lovastatin, simvastatin and atorvastatin
50 Warfarin 500 What proportion of patients on warfarin for atrial fibrillation are taking herbal supps?
51 [48] Warfarin 500 ~50% In one study of patients prescribed warfarin for chronic atrial fibrillation patients taking no herbal medications or only 1 herbal < 4 times per week were more likely to have PT-INR values within the optimal therapeutic range (2.0 to 3.0) compared to those taking > 1 type of herbal 4 times per week (58.1% vs 51.1%, P = 0.046) H.T. Chan, L.T. So, S.W. Li, C.W. Siu, C.P. Lau, H.F. Tse. Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. J Cardiovasc Pharmacol, 58 (1) (2011), pp
52 Miscellaneous 100 What does grapefruit juice do to drug metabolism?
53 Miscellaneous 100 A lot: Grapefruit contains various furanocoumarins that inhibit CYP3A4, potentially resulting in increases in some drug levels. Grapefruit also weakly inhibits intestinal cell P-gp, decreasing the efflux of some absorbed drugs back into the gut lumen. Organic anion transporting polypeptide (OATP) is another transporter system affected by grapefruit. Unlike with CYP3A4 and P-gp, drugs handled by OATP may have decreased absorption when taken with grapefruit, possibly leading to decreased efficacy.
54 Miscellaneous 200 What does omeprazole do to clopidogrel?
55 Miscellaneous 200 It reduces its effectiveness Clopidogrel s anti-platelet activity is entirely the effect of an active metabolite The active metabolite is formed as the result of clopidogrel metabolism by CYP2C19 Omeprazole inhibits CYP2C19 activity.
56 Miscellaneous 300 How do NSAIDs affect lithium therapy?
57 Miscellaneous 300 They reduce renal clearance of lithium and therefore may increase serum levels Both NSAIDs and diuretics may lead to increased proximal resorption of lithium It is recommended that lithium doses be reduced 50% when starting an NSAID or diuretic.
58 Miscellaneous 400 Why are nitrates to be used with caution with phosphodiesterase inhibitors?
59 Miscellaneous 400 Sildafenil and other phosphodiesterase inhibitors potentiate (double) the effect of nitrates All nitrates become NO in vivo NO promote conversion of GTP to cgmp, which leads to smooth muscle relaxation and venodilation cgmp is metabolized/inactivated by phosphodiesterase 5; inhibition leads to greater and more prolonged vasodilation, leading to potentially severe hypotension No nitrates within 24 hours of sildenafil or vardenafil, or within 36 hours of tadalafil
60 Miscellaneous 500 Why must tramadol be used with caution in patients taking SSRIs?
61 Miscellaneous 500 Tramadol exerts its analgesic action through binding of an opiate receptor as well as inhibition of SE and NE uptake Concomitant SSRI use has been reported to lead to the development of serotonin syndrome
62 Cool Drug AEs 100 Name four drugs that can cause this:
63 Cool Drug AEs 100 Pulmonary fibrosis (predominantly lower lobes) Nitrofurantoin Amiodarone Methotrexate Bleomycin Cyclophosphamide Numerous other case reports (see Pneumotox website
64 Cool Drug AEs 200 What is this and what caused it?
65 Cool Drug AEs 200 Flagellate hyperpigmentation from bleomycin Prevalence of flagellate hyperpigmentation in those treated with bleomycin may be as high as 20%. flagellate hyperpigmentation usually fades over a period of several months after the cessation of the medication.
66 Cool Drug AEs 300 What is this and what caused it?
67 Cool Drug AEs 300 HIV lipodystrophy Lipoatrophy associated with thymidine analogue nucleoside RTIs like AZT, d4t Lipohypertrophy less clearly associated with any class; possibly associated with older PIs Metabolic abnormalities (impaired glucose tolerance, dyslipidemia) associated with fat deposition, fat thinning, AZT, d4t, PIs
68 What drug? Cool Drug AEs 400
69 Cool Drug AEs 400 Blue-grey skin hyperpigmentation from amiodarone Occurs in 1-3% of patients on long term low dose amiodarone ( mg/d) May resolve with lower dose or discontinuation (but may take 1+ year)
70 Cool Drug AEs 500 She s bluish but not dyspneic.
71 Methemoglobinemia Causes: sulphonamides Dapsone Local anaesthetics Metocopramide nitrates Cool Drug AEs 500
72 Things to Remember Look for DDIs: When using a DOAC When using anticonvulsants When using macrolides When using amiodarone When dealing with a patient on meds for HIV When dealing with a patient on meds for TB
73
74 Thank you
Self Assessment Question 1
Drug Interactions Bruce G. Pollock, M.D., Ph.D. Professor of Psychiatry, Pharmacology and Nursing Chief, Academic Division of Geriatrics and Neuropsychiatry University of Pittsburgh Medical Center 1 Self
More informationDrug Interactions for the Emergency Physician. Lisa Thurgur
Drug Interactions for the Emergency Physician Lisa Thurgur Objectives Why we should care about drug-drug interactions Cases How can we avoid these interactions Short list of culprit drugs Drug-Drug Interaction
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Dr Susannah O Sullivan Department of Pharmacology University of Auckland 2 Objectives Explain the potential for interacting drugs to cause beneficial and
More informationCytochrome P450 Drug Interaction Table Flockhart Table
Cytochrome P450 Drug Interaction Table Flockhart Table The table contains lists of drugs in columns under the designation of specific cytochrome P450 isoforms. CYTOCHROME P450 DRUG INTERACTION TABLE A
More informationDrug Interactions: Let me count the ways
: Let me count the ways President: PRN Associates, Ltd. Continuing Education in Pharmacology Tucson, AZ Objectives At the conclusion of this continuing education lesson, the participant will be able to:
More informationWho remembers Terfenadine? Once daily non-sedating anti-histamine. Drug Interactions: What is the CYP 450 system? What does the CYP 450 system do?
Drug Interactions: Things that go BOOM! Who remembers Terfenadine? Once daily non-sedating anti-histamine Amelie Hollier, DNP, FNP-BC, FAANP Advanced Practice Education Associates A strange thing happened
More informationAntibiotic Class Interacting Drug Comment Penicillins e.g. Amoxicillin Co amoxiclav Flucloxacillin Phenoxymethylpenicillin
Antibiotic Class Interacting Drug Comment Penicillins Methotrexate Amoxicillin Co amoxiclav Flucloxacillin Phenoxymethylpenicillin Cephalosporins Cefaclor Cefixime Cefuroxime Cephalexin Cefazolin* Ceftriaxone*
More informationA. Definition. B. Epidemiology. C. Classification. i. Pharmacokinetic DIs. ii. Pharmacodynamic DIs. D. Recognition. E. Prevention
DRUG OUTLINE A. Definition B. Epidemiology Dr Ruwan Parakramawansha MBBS, MD, MRCP(UK),MRCPE, DMT(UK) (2013/09/05) C. Classification i. Pharmacokinetic DIs ii. Pharmacodynamic DIs D. Recognition E. Prevention
More informationThe Case of Libby Zion and Dangerous Drug Interactions
The Case of Libby Zion and Dangerous Drug Interactions J.R.White, PA, PharmD I. MAOI and Meperidine Libby Zion 18 yo female Rx c phenelzine (Nardil) Meperidine given for shaking chills Outcome Death Libby
More informationTo understand the formulary process from the hospital perspective
Formulary Process Michael A. Militello, Pharm.D. Cleveland Clinic Cleveland Clinic 2011 Goal and Objectives To understand the formulary process from the hospital perspective p To list the various panels
More informationMORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)
Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories
More informationDrug Interactions: Mechanisms and Potential Clinical Outcomes
: Mechanisms and Potential Clinical Outcomes Alan P. Agins, Ph.D. President PRN Associates, Ltd Continuing Medical Education Tucson, AZ Objectives Specify the two major clinical outcomes of drug interactions
More informationCATEGORIES: QUIZ 2. Drugs Categories. 1. What drug subcategory often ends with the suffix -asone?
CATEGORIES: QUIZ 2 Drugs Categories 1. What drug subcategory often ends with the suffix -asone? a. Alpha blockers b. Corticosteroids c. Calcium channel blockers d. Beta blockers e. ACE inhibitors 2. What
More informationHYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.
Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,
More informationSupplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
More information90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR
Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90
More informationPre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None
Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past
More informationDuragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist
Pre - PA Allowance Quantity 30 patches every 90 days Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist Age 2 years of age or older Diagnosis Patient must have
More informationAntidepressant Pharmacology An Overview
Figure 1. Antidepressant Pharmacology An Overview Source: NEJM 2005;353:1819-34 Figure 2. 1 Figure 3: Antidepressant Pharmacology pictures: Weak inhibition Bupropion NOTE: CYP enzymes noted are those inhibited
More informationGuidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
More informationObjectives. Safe Prescribing and Drug-Drug Interactions for the Nurse Practitioner
Safe Prescribing and Drug-Drug Interactions for the Nurse Practitioner Wendy L. Wright, MS, ANP-BC, FNP-BC, FAANP, FAAN, FNAP Family Nurse Practitioner Owner - Wright & Associates Family Healthcare Amherst,
More informationEdoxaban. Direct Xa inhibitor Direct thrombin inhibitor Direct Xa inhibitor Direct Xa inhibitor
This table provides a summary of the pharmacotherapeutic properties, side effects, drug interactions and other important information on the four anticoagulant medications currently in use or under review
More informationPharmacologic Considerations of HCV Treatment. Autumn Zuckerman, PharmD, BCPS, AAHIVP
Pharmacologic Considerations of HCV Treatment Autumn Zuckerman, PharmD, BCPS, AAHIVP Objectives Review pharmacokinetic properties of currently utilized Hepatitis C medications Review drug interactions
More informationCOMPUTER ALERT FATIGUE DON T IGNORE THESE IMPORTANT DRUG-DRUG INTERACTIONS. Dan Malone, RPh, PhD Professor University of Arizona
COMPUTER ALERT FATIGUE DON T IGNORE THESE IMPORTANT DRUG-DRUG INTERACTIONS Dan Malone, RPh, PhD Professor University of Arizona Disclosures I, Daniel Malone, have no financial relationships to disclose
More informationDaclatasvir (Daklinza ) Drug Interactions with HIV Medications
Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir
More informationPreventing Stroke in Patients with Atrial Fibrillation: USING THE EVIDENCE
Preventing Stroke in Patients with Atrial Fibrillation: USING THE EVIDENCE What Is Atrial Fibrillation? Atrial fibrillation also called AFib or AF is the most common abnormal heart rhythm, affecting an
More informationDrug drug interactions highlighting P450 Cytochromes. Louis Wu, PA-C Presented at VAPAA Annual Meeting March 2, 2017
Drug drug interactions highlighting P450 Cytochromes Louis Wu, PA-C Presented at VAPAA Annual Meeting March 2, 2017 Financial Disclosures and Conflicts I have no financial disclosures nor conflicts concerning
More informationXartemis XR (oxycodone / acetaminophen extended release)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Xartemis XR is a combination of oxycodone and acetaminophen in a dosage formulation to deliver both immediate pain relief, in less than an hour, and extended-release
More informationBRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.
BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation
More informationAppendix IV - Prescribing Guidance for Apixaban
Appendix IV - Prescribing Guidance for Apixaban Patient Factors Dose of Apixaban If your patient has any of the following MAJOR risk factors: Hypersensitivity to the active substance or to any of the excipients
More informationA clinical guide to managing drugdrug interactions in antiretroviral therapy
HIVPA 2008, 6 th June 2008 HIV Pharmacology and TDM B Marta Boffito MD PhD St. Stephen s Centre Chelsea and Westminster Hospital, London A clinical guide to managing drugdrug interactions in antiretroviral
More informationPSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX
A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual
More informationClinical Case Discussion of Drug-Drug Interactions: Minefield or Molehill? David Back
Clinical Case Discussion of Drug-Drug Interactions: Minefield or Molehill? David Back University of Liverpool UK David Back University of Liverpool Rome December 2012 Clinical case: patient characteristics
More informationNucynta IR. Nucynta IR (tapentadol immediate-release) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta IR Page: 1 of 9 Last Review Date: December 8, 2017 Nucynta IR Description Nucynta IR (tapentadol
More informationSUMMARY OF PRODUCT CHARACTERISTICS
WHOPAR part 4 January 2017 Section 6 updated: March 2017 SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 30 WHOPAR part 4 January 2017 Section 6 updated: March 2017 1. NAME OF THE MEDICINAL PRODUCT * 2. QUALITATIVE
More informationDrug Therapy Following Bariatric Surgery
Drug Therapy Following Bariatric Surgery Linda F. McElhiney PharmD, RPh, MSP, FIACP, FACA, FASHP, DPLA Compounding Pharmacist Indiana University Health Disclosures Dr. McElhiney declare(s) no conflicts
More informationRATIONALE FOR INCLUSION IN PA PROGRAM
RATIONALE FOR INCLUSION IN PA PROGRAM Background Tramadol is a centrally acting synthetic opioid analgesic used to treat moderate to moderately severe chronic pain in adults. Along from analgesia, tramadol
More informationQUEST FOR THE IDEAL ANTICOAGULANT: A PATIENT-CENTERED APPROACH TO TREATMENT
QUEST FOR THE IDEAL ANTICOAGULANT: A PATIENT-CENTERED APPROACH TO TREATMENT SATURDAY/11:30AM-12:30PM ACPE UAN: 0107-9999-17-237-L01-T 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning Objectives for
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationInitiation Guide. Images not actual size.
Initiation Guide Images not actual size. INDICATIONS AND USAGE SYMDEKO is indicated for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationImportance of Multi-P450 Inhibition in Drug Drug Interactions: Evaluation of Incidence, Inhibition Magnitude, and Prediction from in Vitro Data
pubs.acs.org/crt Importance of Multi-P450 Inhibition in Drug Drug Interactions: Evaluation of Incidence, Inhibition Magnitude, and Prediction from in Vitro Data Nina Isoherranen,* Justin D. Lutz, Sophie
More informationLevorphanol. Levorphanol Tartrate. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 16, 2018 Levorphanol Description Levorphanol
More informationMental Health DNA Insight WHITE PAPER
Mental Health DNA Insight WHITE PAPER JULY 2016 Mental Health DNA Insight / White Paper Mental Health DNA Insight Pathway Genomics Mental Health DNA Insight test is aimed to help psychiatrists, neurologists,
More informationOXYCODONE IR (oxycodone)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Oxycodone hydrochloride, a pure opioid agonist, is used in the treatment of moderate to severe pain (1-2). The precise mechanism of action is unknown; however,
More informationKiller Drug Interactions. Karen Curzio Rodeghiero, PharmD, BCPS Clinical Pharmacist, Emergency Medicine Piedmont Athens Regional
Killer Drug Interactions Karen Curzio Rodeghiero, PharmD, BCPS Clinical Pharmacist, Emergency Medicine Piedmont Athens Regional Disclosure I have no financial interests or relationships to disclose Primum
More informationButrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Butrans Page: 1 of 9 Last Review Date: September 15, 2017 Butrans (buprenorphine patch) Description
More informationSUMMARY OF PRODUCT CHARACTERISTICS
Section 6 updated: March 2017 SUMMARY OF PRODUCT CHARACTERISTICS 1 Section 6 updated: March 2017 1. NAME OF THE MEDICINAL PRODUCT Ritonavir Tablets 100 mg * 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationBelbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2017 Belbuca (buprenorphine buccal film)
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize
More informationNOACS/DOACS*: COMPARISON AND FREQUENTLY-ASKED QUESTIONS
NOACS/DOACS*: COMPARISON AND FREQUENTLY-ASKED QUESTIONS OBJECTIVES: To provide a comparison of the newer direct oral anticoagulants (DOACs) currently available in Canada. To address frequently-asked questions
More informationDemerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Meperidine Page: 1 of 7 Last Review Date: September 15, 2017 Meperidine Description Demerol (meperidine
More informationDrugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
More informationRISK FACTORS AND DRUG TO STATIN-INDUCED MYOPATHY
RISK FACTORS AND DRUG INTERACTION PREDISPOSING TO STATIN-INDUCED MYOPATHY Assist. Prof. Dr. Verawan Uchaipichat Clinical Pharmacy Department Khon Kaen University Advanced Pharmacotherapy 2012 Updated d
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More informationGUIDANCE FOR LEAPFROG HOSPITAL SURVEY PARTICIPATING HOSPITALS CLINICAL DECISION SUPPORT RELATED TO THE CPOE EVALUATION TOOL
GUIDANCE FOR LEAPFROG HOSPITAL SURVEY PARTICIPATING HOSPITALS CLINICAL DECISION SUPPORT RELATED TO THE CPOE EVALUATION TOOL CPOE Evaluation Tool Guidance Last Updated 04/01/2018 1 INTRODUCTION To fully
More informationCARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
More informationBELBUCA (buprenorphine buccal film)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Belbuca is indicated for the management of chronic pain severe enough to require daily, aroundthe-clock, long-acting opioid treatment for which alternative
More informationJolene R. Bostwick, PharmD, BCPS, BCPP Clinical Associate Professor Associate Chair, Department of Clinical Pharmacy University of Michigan College
Jolene R. Bostwick, PharmD, BCPS, BCPP Clinical Associate Professor Associate Chair, Department of Clinical Pharmacy University of Michigan College of Pharmacy Clinical Pharmacist in Psychiatry University
More informationeview Top 10 Prescribed Drugs: Important Interactions Karen A. Jensen, MSc, BSP yright t for Sale or Commercial Distribution
Top 10 Prescribed Drugs: Important Interactions Karen A. Jensen, MSc, BSP Presented at the University of Saskatchewan s 4th Annual Peter and Anna Zbeetnoff Memorial Drug Therapy Decision-Making Conference,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Norvir 80 mg/ml oral solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of oral solution contains 80 mg of ritonavir.
More informationHysingla ER. Hysingla ER (hydrocodone bitartrate) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.38 Subject: Hysingla ER Page: 1 of 9 Last Review Date: September 15, 2017 Hysingla ER Description
More informationALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationMorphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone),
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.33 Subject: Morphine IR Drug Class Page: 1 of 11 Last Review Date: December 8, 2017 Morphine IR Hydromorphone
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationConcomitant antiretroviral therapy : Avifanz must be given in combination with other antiretroviral medications.
Avifanz Tablet Description Avifanz is the brand name for Efavirenz. Efavirenz, a synthetic antiretroviral agent, is a non-nucleoside reverse transcriptase inhibitor. While Efavirenz is pharmacologically
More informationSMOKING AND DRUG INTERACTIONS
Medicines Information Centre Pharmacy Department UK Medicines Information SMOKING AND DRUG INTERACTIONS Introduction Smoking rates are significantly higher among people with mental health problems. It
More informationVolume 4; Number 5 May 2010
Volume 4; Number 5 May 2010 CLINICAL GUIDELINES FOR ANTIDEPRESSANT USE IN PRIMARY AND SECONDARY CARE Lincolnshire Partnership Foundation Trust in conjunction with Lincolnshire PACEF have recently updated
More informationAntidepressant Treatment of Depression
Antidepressant Treatment of Depression PLEASE REFER TO INTEGRATED CARE PATHWAY FOR INFORMATION RELATING TO THE OVERALL MANAGEMENT OF DEPRESSION SSRI s are first choice agents because they are as effective
More informationEmbeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.39 Subject: Embeda Page: 1 of 8 Last Review Date: September 15, 2017 Embeda Description Embeda (morphine
More informationPsychotropic Drug Interactions Over the past 2 decades:
Psychotropic Drug Interactions Over the past 2 decades: Treatment options: Several and non- therapies Increasing number of psychotropic s Increased risk of adverse outcomes Overwhelming information on
More informationLevorphanol. Levorphanol Tartrate. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 17, 2017 Levorphanol Description Levorphanol
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationCurrent Drugs: Drug-Drug Interactions
Slide 1 Current Drugs: Drug-Drug Interactions David Back University of Liverpool UK David Back University of Liverpool May 2013 Toxicity HCV med Comed Reduced Efficacy The major effect of DAAs is to increase
More informationRecommended dosing for pediatric patients (6 months to 12 years of age) 1. Dose based on lopinavir component* 1.25 ml ml
Abbott Virology 100 Abbott Park Road Abbott Park, IL 60064 KALETRA 100/25 mg tablets NDC #0074-0522-60 Dear Healthcare Provider: Introducing a new strength of KALETRA (lopinavir/ritonavir): 100/25 mg tablets
More informationQuetiapine Case 1 Warfarin Jose de Leon, MD
Quetiapine Case 1 Warfarin 1-23-16 Jose de Leon, MD 1. Quetiapine Case 1 J Clin Psychopharm 1999;19:382-3 http://www.ncbi.nlm.nih.gov/pubmed/10440472 Educational Objectives At the conclusion of this presentation,
More informationDuragesic patch. Duragesic patch (fentanyl patch) Description. Section: Prescription Drugs Effective Date: January 1, 2019
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Duragesic patch Page: 1 of 9 Last Review Date: November 30, 2018 Duragesic patch Description Duragesic patch (fentanyl
More informationDOAC for VTE. Direct Oral Anticoagulants Clint Shedd DNP, FNP-BC Emory University
DOAC for VTE Direct Oral Anticoagulants Clint Shedd DNP, FNP-BC Emory University No disclosures Direct Oral Anticoagulants Understand VTE and the ACCP s position on it List the DOACs available in the US
More informationBelbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2016 Belbuca (buprenorphine buccal film)
More information12/9/2015. Drug Interactions. Sarah Robertson, Pharm.D. Director, Department of Clinical Pharmacology Vertex Pharmaceuticals Inc.
Drug Interactions Sarah Robertson, Pharm.D. Director, Department of Clinical Pharmacology Vertex Pharmaceuticals Inc. Boston, MA, USA December 10, 2015 1 1 Overview Epidemiology and Categories of Drug
More information- how many anti-depressant pills were prescribed to patients in years 2011/12/13
NHS Wet Kent Clinical Commiioning Group Our Ref: FOI.14.WK0196 RE: FREEDOM OF INFORMATION REQUEST Thank you for your requet for information under the Freedom of Information Act 2000 received on 25 February
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationEvaluation of Drug-Drug Interactions FDA Perspective
Evaluation of Drug-Drug Interactions FDA Perspective Kellie Schoolar Reynolds, Pharm.D. Deputy Director Division of Clinical Pharmacology IV Office of Clinical Pharmacology Office of Translational Sciences
More information4.3 Antidepressants (ADDs) BNF Section 4.3
4.3 Antidepressants (ADDs) BNF Section 4.3 The aim of this guidance is to provide prescribing guidance and highlight good practice. It is not intended to be a comprehensive practice treatment guideline.
More informationOral Anticoagulants Update. Elizabeth Renner, PharmD, BCPS, BCACP, CACP Outpatient Cardiology and Anticoagulation
Oral Anticoagulants Update Elizabeth Renner, PharmD, BCPS, BCACP, CACP Outpatient Cardiology and Anticoagulation Objectives List the direct oral anticoagulant (DOAC) drugs currently available Describe
More informationDuragesic patch. Duragesic patch (fentanyl patch) Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Subject: Duragesic patch Page: 1 of 9 Last Review Date: September 15, 2017 Duragesic patch Description Duragesic patch (fentanyl
More informationOriginal Research Article Actual and Potential Drug Interactions Associated with Methadone
Blackwell Publishing IncMalden, USAPMEPain Medicine1526-23752007 Blackwell Publishing Ltd? 200793315344Review Article Actual and Potential Drug Interactions Associated with MethadoneWeschules et al. PAIN
More informationNEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS
NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS OBJECTIVES: To provide a comparison of the new/novel oral anticoagulants (NOACs) currently available in Canada. To address
More informationDrug Interactions: Definition
Drug Interactions Scott R. Penzak, Pharm.D. Director, Clinical Pharmacokinetics Research Laboratory Clinical Center Pharmacy Department National Institutes of Health December 9, 2010 Drug Interactions:
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationGuidelines on Choice and Selection of Antidepressants for the Management of Depression
Guidelines on Choice and Selection of Antidepressants for the Management of Depression 1. Introduction This guidance should be considered as part of a stepped care approach in the management of depressive
More informationpatient group direction
ASPIRIN v01 1/8 ASPIRIN PGD Details Version 1.0 Legal category P Staff grades Approved by Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)
More informationTreatments for stroke prevention in Atrial Fibrillation as recommended by the Canadian Cardiovascular Society
Treatments for stroke prevention in Atrial Fibrillation as recommended by the Canadian Cardiovascular Society Coumadin (Warfarin) Does this medication need ongoing monitoring of blood clotting times? Yes.
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationInteractions Between Herbal Medicines and Prescribed Drugs
REVIEW ARTICLE Drugs 2009; 69 (13): 1777-1798 0012-6667/09/0013-1777/$55.55/0 ª 2009 Adis Data Information BV. All rights reserved. Interactions Between Herbal Medicines and Prescribed Drugs An Updated
More informationClinical Pharmacology of DAA s for HCV: What s New & What s In Pipeline
Clinical Pharmacology of DAA s for HCV: What s New & What s In Pipeline Kirk Bertelsen, PhD Clinical Pharmacology Janssen Pharmaceuticals, Research & Development 4/24/2013 1 Incivo Simeprevir 2 Janssen
More informationDNA & Allergen Compatibility Report
DNA & Allergen Compatibility Report REPORT FOR: JOHN W. DOE 11.21.2017 John W. Doe Personal Profile CURRENT MEDICATIONS: FOOD: Advil 07.11.2017 Clopidogrel 07.23.2017 Doxepin 09.04.2017 Fluoxetine 09.17.2017
More informationThere is some evidence to suggest that the half-life of felbamate may be prolonged by gabapentin.
amciclovir amciclovir + Probenecid Probenecid is predicted to increase the exposure to penciclovir, the active metabolite of famciclovir, possibly resulting in increased adverse effects. Evidence is limited
More informationNHS Kent and Medway Medicines Management. Dronedarone (Multaq ) Shared Care Guideline For Prescribing
NHS Kent and Medway Medicines Management Dronedarone (Multaq ) Shared Care Guideline For Prescribing Issue No: 2 Review Date (If Applicable): Accountable Officer: Heather Lucas Contact Details: 01233 618158
More information